Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Metals Regulatory News (FME)

  • There is currently no data for FME

Appendix 5B

31 Jan 2022 07:46

RNS Number : 1160A
Future Metals NL
31 January 2022
 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

Future Metals NL

ABN

 

Quarter ended ("current quarter")

99 124 734 961

31 December 2021

 

Consolidated statement of cash flows

(refer Note 1)

Current quarter$A'000

Year to date

(6 months)$A'000

1.

Cash flows from operating activities

-

-

1.1

Receipts from customers

1.2

Payments for

-

-

(a) exploration & evaluation

(b) development

-

-

(c) production

-

-

(d) staff costs

-

-

(e) administration and corporate costs

(445)

(747)

1.3

Dividends received (see note 3)

-

-

1.4

Interest received

1

3

1.5

Interest and other costs of finance paid

-

-

1.6

Income taxes paid

-

-

1.7

Government grants and tax incentives

-

-

1.8

Other (provide details if material)

1.9

Net cash from / (used in) operating activities

(444)

(744)

2.

Cash flows from investing activities

-

-

2.1

Payments to acquire or for:

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

(44)

(d) exploration & evaluation

(1,440)

(2,112)

(e) investments

-

-

(f) other non-current assets

-

-

2.2

Proceeds from the disposal of:

-

-

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) investments

-

-

(e) other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see note 3)

-

-

2.5

Other

2.6

Net cash from / (used in) investing activities

(1,440)

(2,156)

3.

Cash flows from financing activities

-

-

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

-

-

3.3

Proceeds from exercise of options

-

-

3.4

Transaction costs related to issues of equity securities or convertible debt securities

 

-

 

-

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7

Transaction costs related to loans and borrowings

-

-

3.8

Dividends paid

-

-

3.9

Other (provide details if material)

- costs for and associated with the public offer and ASX|AIM Listing

 

 

(705)

 

 

(1,054)

3.10

Net cash from / (used in) financing activities

(705)

(1,054)

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

8,191

9,556

4.2

Net cash from / (used in) operating activities (item 1.9 above)

(444)

(744)

4.3

Net cash from / (used in) investing activities (item 2.6 above)

(1,440)

(2,156)

4.4

Net cash from / (used in) financing activities (item 3.10 above)

(705)

(1,054)

4.5

Effect of movement in exchange rates on cash held

-

-

4.6

Cash and cash equivalents at end of period

5,602

5,602

 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$A'000

Previous quarter$A'000

5.1

Bank balances

3,282

5,873

5.2

Call deposits

2,320

2,318

5.3

Bank overdrafts

-

-

5.4

Other (provide details)

-

-

5.5

Cash and cash equivalents at end of quarter (should equal item 4.6 above)

5,602

8,191

 

6.

Payments to related parties of the entity and their associates

Current quarter$A'000

6.1

Aggregate amount of payments to related parties and their associates included in item 1

169

6.2

Aggregate amount of payments to related parties and their associates included in item 2

-

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

 

- Payment of Directors' Fees and Remuneration - $169k

 

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter end$A'000

Amount drawn at quarter end$A'000

7.1

Loan facilities

7.2

Credit standby arrangements

7.3

Other (please specify)

7.4

Total financing facilities

7.5

Unused financing facilities available at quarter end

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

 

 

 

 

8.

Estimated cash available for future operating activities

$A'000

8.1

Net cash from / (used in) operating activities (item 1.9)

(444)

8.2

(Payments for exploration & evaluation classified as investing activities) (item 2.1(d))

(1,440)

8.3

Total relevant outgoings (item 8.1 + item 8.2)

(1,884)

8.4

Cash and cash equivalents at quarter end (item 4.6)

5,602

8.5

Unused finance facilities available at quarter end (item 7.5)

-

8.6

Total available funding (item 8.4 + item 8.5)

5,602

8.7

Estimated quarters of funding available (item 8.6 divided by item 8.3)

3.0

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in item 8.3, answer item 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

8.8

If item 8.7 is less than 2 quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer: N/A

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer: N/A

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer: N/A

Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

 

 

Date: 31 January 2022

 

 

Authorised by: Aaron Bertolatti - Company Secretary

 

(Name of body or officer authorising release - see note 4)

 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUWWGUPPUMG
Date   Source Headline
5th Nov 20257:00 amRNSCancellation - Future Metals NL
31st Oct 20256:00 pmRNSFuture Metals NL
30th Oct 20257:00 amRNSQuarterly Activities Report
24th Oct 20259:00 amRNSNotice of AGM
7th Oct 20258:46 amRNSCancellation of Admission to AIM
29th Sep 20258:06 amRNSAppointment of Managing Director and CEO
26th Sep 20259:06 amRNSFinal Results for the Year Ended 30 June 2025
30th Jul 20257:00 amRNSQuarterly Activities Report
16th Jul 20257:00 amRNSDirector / PDMR Dealing
11th Jul 20258:37 amRNSSignificant Shareholder Interest
20th Jun 20258:00 amRNSResults of Non-Renounceable Entitlement Offer
4th Jun 20257:00 amRNSEntitlement Offer Fully Underwritten
27th May 20259:17 amRNSEntitlement Offer – Extension of Closing Date
15th May 20257:01 amRNSEntitlement Offer Details for DI Holders
15th May 20257:00 amRNSCommencement of Entitlement Offer
7th May 20257:15 amRNSLaunch of A$2.64m (£1.28m) Entitlement Offer
30th Apr 20257:00 amRNSQuarterly Activities Report
23rd Apr 20259:04 amRNSCompletion of Placement
10th Apr 20257:00 amRNSStrategic Infrastructure MOU and Equity Fundraise
8th Apr 20258:01 amRNSASX Trading Halt
12th Mar 202512:54 pmRNSResults for the Half-Year Ended 31 December 2024
17th Feb 20257:01 amRNSASX Price Query Response
17th Feb 20257:00 amRNSCompany Update
30th Jan 20257:00 amRNSQuarterly Activities Report
19th Dec 20247:00 amRNSChange of Company Secretary
21st Nov 20241:01 pmRNSResult of AGM and Board Changes
11th Nov 20248:48 amRNSResignation of Non-Executive Director
31st Oct 20249:25 amRNSQuarterly Activities Report
30th Oct 202412:00 pmRNSReplacement: Company Update
29th Oct 20247:00 amRNSCompany Update
18th Oct 20248:00 amRNSNotice of AGM
11th Oct 20247:00 amRNS2024 AGM and Director Nominations
9th Oct 20247:00 amRNSDrilling Underway at Eileen Bore
30th Sep 20241:30 pmRNSFinal Results for the Year Ended 30 June 2024
16th Sep 20247:00 amRNSHeritage Surveys Completed & Testing Eileen Bore
21st Aug 20247:00 amRNSResults of the Option Offer and Shortfall
9th Aug 20248:07 amRNSCompany Update
31st Jul 20248:00 amRNSOption Offer
29th Jul 20249:30 amRNSQuarterly Activities Report
4th Jul 20243:01 pmRNSChange of Auditor & Issue of Underwriter Options
3rd Jul 20242:16 pmRNSGrant of Director Performance Rights
2nd Jul 202412:45 pmRNSIssue of Equity and Change of Registered Office
25th Jun 20249:00 amRNSResults of General Meeting
12th Jun 20247:00 amRNSExercise of Quoted Options
24th May 20247:00 amRNSNotice of General Meeting
22nd May 20248:30 amRNSRelease of Securities from Voluntary Escrow
21st May 20249:22 amRNSIssue of Consideration Shares
14th May 20247:00 amRNSReceipt of A$180,000 EIS Grant
10th May 20248:00 amRNSNotification of Expiry of Quoted Options
3rd May 202410:15 amRNSProposed Options Entitlement Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.